Evidence map›Paper›PMID 32601372›Full record

ArticleNature cell biology2020

Unrestrained ESCRT-III drives micronuclear catastrophe and chromosome fragmentation.

Marina Vietri, Sebastian W Schultz, Aurélie Bellanger, Carl M Jones, Louise I Petersen, Camilla Raiborg, Ellen Skarpen, Christeen Ramane J Pedurupillay, Ingrid Kjos, Eline Kip and 10 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Nature cell biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed
6.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 134 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. ESCRT-III function in membrane fission and repair.Nature reviews. Molecular cell biology · 2026
    Review
  8. Micronuclei: origins, assays, mechanisms, diseases and treatments.Signal transduction and targeted therapy · 2026
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 4 institutions in 4 countries.

Marina VietriCentre for Cancer Cell Reprogramming, Faculty of Medicine, University of Oslo, Oslo, Norway.
Sebastian W Schultz *Centre for Cancer Cell Reprogramming, Faculty of Medicine, University of Oslo, Oslo, Norway.
Aurélie Bellanger *Department of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.ORCID http://orcid.org/0000-0002-7573-7416
Carl M JonesDepartment of Biological Sciences, Durham University, Durham, UK.
Louise I PetersenDepartment of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
Camilla RaiborgCentre for Cancer Cell Reprogramming, Faculty of Medicine, University of Oslo, Oslo, Norway.ORCID http://orcid.org/0000-0002-5406-5403
Ellen SkarpenCentre for Cancer Cell Reprogramming, Faculty of Medicine, University of Oslo, Oslo, Norway.
Christeen Ramane J PedurupillaySection for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway.
Ingrid KjosCentre for Cancer Cell Reprogramming, Faculty of Medicine, University of Oslo, Oslo, Norway.ORCID http://orcid.org/0000-0002-9166-3074
Eline KipCentre for Cancer Cell Reprogramming, Faculty of Medicine, University of Oslo, Oslo, Norway.
Romy TimmerDepartment of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.ORCID http://orcid.org/0000-0002-1710-4397
Ashish JainCentre for Cancer Cell Reprogramming, Faculty of Medicine, University of Oslo, Oslo, Norway.
Philippe CollasDepartment of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
Roland L KnorrMax Planck Institute of Colloids and Interfaces, Department of Theory and Bio-Systems, Potsdam, Germany.ORCID http://orcid.org/0000-0002-6747-0088
Sushma N GrellscheidDepartment of Biological Sciences, Durham University, Durham, UK.
Halim KusumaatmajaDepartment of Physics, Durham University, Durham, UK.ORCID http://orcid.org/0000-0002-3392-9479
Andreas BrechCentre for Cancer Cell Reprogramming, Faculty of Medicine, University of Oslo, Oslo, Norway.
Francesca MicciSection for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway.
Harald StenmarkCentre for Cancer Cell Reprogramming, Faculty of Medicine, University of Oslo, Oslo, Norway. stenmark@ulrik.uio.no.ORCID http://orcid.org/0000-0002-1971-4252
Coen CampsteijnDepartment of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway. coen.campsteijn@medisin.uio.no.ORCID http://orcid.org/0000-0001-5286-1521
Oslo University Hospital · NOUniversity of Oslo · NODurham University · GBMax Planck Institute of Colloids and Interfaces · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ESCRT-III membrane fission machinery maintains the integrity of the nuclear envelope. Although primary nuclei resealing takes minutes, micronuclear envelope ruptures seem to be irreversible. Instead, micronuclear ruptures result in catastrophic membrane collapse and are associated with chromosome fragmentation and chromothripsis, complex chromosome rearrangements thought to be a major driving force in cancer development. Here we use a combination of live microscopy and electron tomography, as well as computer simulations, to uncover the mechanism underlying micronuclear collapse. We show that, due to their small size, micronuclei inherently lack the capacity of primary nuclei to restrict the accumulation of CHMP7-LEMD2, a compartmentalization sensor that detects loss of nuclear integrity. This causes unrestrained ESCRT-III accumulation, which drives extensive membrane deformation, DNA damage and chromosome fragmentation. Thus, the nuclear-integrity surveillance machinery is a double-edged sword, as its sensitivity ensures rapid repair at primary nuclei while causing unrestrained activity at ruptured micronuclei, with catastrophic consequences for genome stability.

Indexed as

Chromosome AberrationsDNA DamageGenomic InstabilityCell NucleusChromatinEndosomal Sorting Complexes Required for TransportHeLa CellsHumansMembrane ProteinsNuclear ProteinsChromatinEndosomal Sorting Complexes Required for TransportLEMD2 protein, humanMembrane ProteinsNuclear Proteins

Identifiers

PMID32601372
OpenAlexW3037469178

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.